Optic Nerve Injury
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy (NCT07777861) | Qingdao WanMing BioCell Pharmaceutics Co.,Ltd. | 2026-03-18 |
Track Optic Nerve Injury automatically
Every clearance here is in the API, with alerts when new ones post.